Form 4: SeaStar Medical Officer Granted 7,500 RSUs

SeaStar Medical's Principal Accounting Officer, Bradford K. Towne, was granted 7,500 restricted stock units vesting over three years.

Summary

• Bradford K. Towne, Principal Accounting Officer of SeaStar Medical Holding Corp (ICU), was granted 7,500 shares of common stock in the form of Restricted Stock Units (RSUs).
• The transaction date for the RSU award is February 6, 2026.
• The RSUs will vest in equal installments on the first, second, and third anniversaries of February 6, 2026.
• Following this transaction, Towne beneficially owns 9,050 shares of common stock directly.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-planned equity award.
• Eric Schlorff, Chief Executive Officer of SeaStar Medical Holding Corp, signed the Form 4 as attorney-in-fact for Bradford Towne, as authorized by a Power of Attorney dated February 10, 2026.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, reflecting standard executive compensation practices that align management incentives with long-term company performance and shareholder interests.

Positives

• The grant of 7,500 Restricted Stock Units (RSUs) to a Principal Accounting Officer aligns management's interests with shareholders.
• The RSU award vests over three years, promoting long-term retention and performance incentives.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-planned and transparent equity award.

Future Outlook

The RSU award to Bradford K. Towne is structured to vest in equal installments on the first, second, and third anniversaries of February 6, 2026, indicating a future commitment and incentive for the Principal Accounting Officer.

Management Comments

• The undersigned acknowledges that no such attorney-in-fact, in serving in such capacity at the request of the undersigned, is hereby assuming any of the undersigneds responsibilities to comply with Section 13 and Section 16 of the Securities Exchange Act of 1934, as amended, and the rules thereunder.

Industry Context

StockSavvy.ai notes that RSU grants are a common form of executive compensation in the biotechnology and medical device sectors, aiming to retain key talent and align their long-term interests with shareholder value creation. This grant to a Principal Accounting Officer is standard practice for incentivizing financial leadership.

Comparison to Industry Standards

• The grant of RSUs as a component of executive compensation is a widely adopted practice across various industries, including healthcare and technology, comparable to companies like Medtronic or Intuitive Surgical, which frequently use equity awards to incentivize executives.
• The three-year vesting schedule is typical for RSU awards, aligning with industry benchmarks for long-term incentive plans designed to promote executive retention and sustained performance.
• The use of a Rule 10b5-1 plan for the transaction is a standard corporate governance practice, ensuring transparency and compliance with insider trading regulations, similar to practices at major public companies.

Corporate Governance

Stakeholder Impact

• Shareholders: The RSU grant aligns the Principal Accounting Officer's long-term interests with shareholder value creation, potentially leading to more diligent financial management.
• Employees: Standard executive compensation practices, including RSU grants, can signal stability and a structured approach to rewarding leadership.

Next Steps

• First installment of RSU award vests on February 6, 2027.
• Second installment of RSU award vests on February 6, 2028.
• Third installment of RSU award vests on February 6, 2029.

Key Dates

Recommendation

This Form 4 filing details a routine RSU grant to a key executive, which is a standard compensation practice aimed at aligning management incentives with long-term company performance. While positive for executive retention and motivation, it does not present new information that would significantly alter the company's fundamental valuation or immediate outlook, thus warranting a 'hold' recommendation for existing investors.

Keywords

SeaStar Medical Holding Corp, ICU, Form 4, Restricted Stock Units, RSU, Insider Trading, Executive Compensation, Equity Grant, Bradford K. Towne, Principal Accounting Officer, Rule 10b5-1